[Retracted] Effects of Ulinastatin on Myocardial Ischemia-Reperfusion Injury, Cardiac Function, and Serum TNF-α and IL-10 Levels in Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass

Table 3

Comparison of clinical efficacy and safety ( (%)).

	Obs group	Con group
Total effective rate (%)	90.38	86.54	0.377	0.539
Significant	30 (57.69)	26 (50.00)
Efficient	17 (32.69)	19 (36.54)
Invalid	5 (9.62)	7 (13.46)
Total incidence (%)	7.68	11.54	0.443	0.506
Lung infection	1 (1.92)	1 (1.92)
Atelectasis	1 (1.92)	2 (3.85)
Impairment of shoulder mobility	1 (1.92)	2 (3.85)
Fever and vomiting	1 (1.92)	1 (1.92)